Effects of Neonatal Treatment with Valproic Acid on Vasopressin Immunoreactivity and Olfactory Behaviour in Mice

Journal of Neuroendocrinology

Volumn 23, Issue 10, 2011, Pages 906-914

  Murray, E K ^a   Varnum, M M ^a   Fernandez, J L ^a   De Vries, G J ^a   Forger, N G ^a  

^a UNIVERSITY OF MASSACHUSETTS   (United States)

Author keywords

Acetylation; Epigenetic; Histone; Olfactory behaviour; Sexual differentiation; Vasopressin

Indexed keywords

ESTRADIOL; ESTRADIOL BENZOATE; HISTONE; PROGESTERONE; TESTOSTERONE; VALPROIC ACID; VASOPRESSIN;

ACETYLATION; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DNA METHYLATION; DNA MODIFICATION; DRUG EFFECT; DRUG IMPLANT; ENZYME LINKED IMMUNOSORBENT ASSAY; EPIGENETICS; ESTRADIOL BLOOD LEVEL; FEMALE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MALE; MOUSE; NERVE CELL; NEUROCHEMISTRY; NEWBORN; NONHUMAN; OLFACTORY NERVOUS SYSTEM; OVARIECTOMY; PRIORITY JOURNAL; RADIOIMMUNOASSAY; SEX DIFFERENCE; SEX DIFFERENTIATION; STRIA TERMINALIS; TESTOSTERONE BLOOD LEVEL; THALAMUS;

ANIMALS; ANIMALS, NEWBORN; FEMALE; IMMUNOHISTOCHEMISTRY; MALE; MICE; MICE, INBRED C57BL; SMELL; VALPROIC ACID; VASOPRESSINS;

EID: 80053164991     PISSN: 09538194     EISSN: 13652826     Source Type: Journal    
DOI: 10.1111/j.1365-2826.2011.02196.x     Document Type: Article

References (51)

1. Gore AC. Developmental programming and endocrine disruptor effects on reproductive neuroendocrine systems. Front Neuroendocrinol 2008; 29: 358-374.
2. Patisaul HB, Adewale HB. Long-term effects of environmental endocrine disruptors on reproductive physiology and behavior. Front Behav Neurosci. 2009; 3: 10.
3. Meaney MJ, Szyf M. Environmental programming of stress responses through DNA methylation: life at the interface between a dynamic environment and a fixed genome. Dialogues Clin Neurosci 2005; 7: 103-123.
4. Nugent BM, Schwarz JM, McCarthy MM. Hormonally mediated epigenetic changes to steroid receptors in the developing brain: implications for sexual differentiation. Horm Behav 2011; 59: 388-344.
5. McCarthy MM, Auger AP, Bale TL, De Vries GJ, Dunn GA, Forger NG, Murray EK, Nugent BM, Schwarz JM, Wilson ME. The epigenetics of sex differences in the brain. J Neurosci 2009; 29: 12815-12823.
6. Cooke B, Hegstrom CD, Villeneuve LS, Breedlove SM. Sexual differentiation of the vertebrate brain: principles and mechanisms. Front Neuroendocrinol 1998; 19: 323-362.
7. Spencer TE, Jenster G, Burcin MM, Allis CD, Zhou J, Mizzen CA, McKenna NJ, Onate SA, Tsai SY, Tsai MJ, O'Malley BW. Steroid receptor coactivator-1 is a histone acetyltransferase. Nature 1997; 389: 194-198.
8. Kishimoto M, Fujiki R, Takezawa S, Sasaki Y, Nakamura T, Yamaoka K, Kitagawa H, Kato S. Nuclear receptor mediated gene regulation through chromatin remodeling and histone modifications. Endocr J 2006; 53: 157-172.
9. Murray EK, Hien A, de Vries GJ, Forger NG. Epigenetic control of sexual differentiation of the bed nucleus of the stria terminalis. Endocrinology 2009; 150: 4241-4247.
10. Caldwell HK, Lee HJ, Macbeth AH, Young WS III. Vasopressin: behavioral roles of an 'original' neuropeptide. Prog Neurobiol 2008; 84: 1-24.
11. de Vries GJ, Miller MA. Anatomy and function of extrahypothalamic vasopressin systems in the brain. Prog Brain Res 1998; 119: 3-20.
12. Goodson JL, Bass AH. Social behavior functions and related anatomical characteristics of vasotocin/vasopressin systems in vertebrates. Brain Res Brain Res Rev 2001; 35: 246-265.
13. De Vries GJ, Panzica GC. Sexual differentiation of central vasopressin and vasotocin systems in vertebrates: different mechanisms, similar endpoints. Neuroscience 2006; 138: 947-955.
14. Rood BD, de Vries GJ. Vasopressin innervation of the mouse (Mus musculus) brain and spinal cord. J Comp Neurol 2011; 519: 2434-2474.
15. Wang Z, De Vries GJ. Testosterone effects on paternal behavior and vasopressin immunoreactive projections in prairie voles (Microtus ochrogaster). Brain Res 1993; 631: 156-160.
16. Han TM, De Vries GJ. Organizational effects of testosterone, estradiol, and dihydrotestosterone on vasopressin mRNA expression in the bed nucleus of the stria terminalis. J Neurobiol 2003; 54: 502-510.
17. Lonstein JS, Rood BD, de Vries GJ. Unexpected effects of perinatal gonadal hormone manipulations on sexual differentiation of the extrahypothalamic arginine-vasopressin system in prairie voles. Endocrinology 2005; 146: 1559-1567.
18. Wysocki CJ. Neurobehavioral evidence for the involvement of the vomeronasal system in mammalian reproduction. Neurosci Biobehav Rev 1979; 3: 301-341.
19. Beauchamp GK, Martin IG, Wysocki CJ, Wellington JL. Chemoinvestigatory and sexual behavior of male guinea pigs following vomeronasal organ removal. Physiol Behav 1982; 29: 329-336.
20. Portillo W, Paredes RG. Sexual incentive motivation, olfactory preference, and activation of the vomeronasal projection pathway by sexually relevant cues in non-copulating and naive male rats. Horm Behav 2004; 46: 330-340.
21. Petrulis A, Peng M, Johnston RE. Effects of vomeronasal organ removal on individual odor discrimination, sex-odor preference, and scent marking by female hamsters. Physiol Behav 1999; 66: 73-83.
22. Bodo C, Rissman EF. Androgen receptor is essential for sexual differentiation of responses to olfactory cues in mice. Eur J Neurosci 2007; 25: 2182-2190.
23. Bodo C, Rissman EF. The androgen receptor is selectively involved in organization of sexually dimorphic social behaviors in mice. Endocrinology 2008; 149: 4142-4150.
24. DeVries GJ, Buijs RM, Van Leeuwen FW, Caffe AR, Swaab DF. The vasopressinergic innervation of the brain in normal and castrated rats. J Comp Neurol 1985; 233: 236-254.
25. Hoorneman EM, Buijs RM. Vasopressin fiber pathways in the rat brain following suprachiasmatic nucleus lesioning. Brain Res 1982; 243: 235-241.
26. Rood BD, Murray EK, Laroche J, Yang MK, Blaustein JD, De Vries GJ. Absence of progestin receptors alters distribution of vasopressin fibers but not sexual differentiation of vasopressin system in mice. Neuroscience 2008; 154: 911-921.
27. Yang X, Schadt EE, Wang S, Wang H, Arnold AP, Ingram-Drake L, Drake TA, Lusis AJ. Tissue-specific expression and regulation of sexually dimorphic genes in mice. Genome Res 2006; 16: 995-1004.
28. Forger NG, Rosen GJ, Waters EM, Jacob D, Simerly RB, de Vries GJ. Deletion of Bax eliminates sex differences in the mouse forebrain. Proc Natl Acad Sci USA 2004; 101: 13666-13671.
29. Hisasue SI, Seney ML, Immerman E, Forger NG. Control of cell number in the bed nucleus of the stria terminalis of mice: role of testosterone metabolites and estrogen receptor subtypes. J Sex Med 2010; 7: 1401-1409.
30. De Vries GJ, Duetz W, Buijs RM, van Heerikhuize J, Vreeburg JT. Effects of androgens and estrogens on the vasopressin and oxytocin innervation of the adult rat brain. Brain Res 1986; 399: 296-302.
31. Pinder RM, Brogden RN, Speight TM, Avery GS. Sodium valproate: a review of its pharmacological properties and therapeutic efficacy in epilepsy. Drugs 1977; 13: 81-123.
32. Blaheta RA, Cinatl J Jr. Anti-tumor mechanisms of valproate: a novel role for an old drug. Med Res Rev 2002; 22: 492-511.
33. Dash PK, Orsi SA, Zhang M, Grill RJ, Pati S, Zhao J, Moore AN. Valproate administered after traumatic brain injury provides neuroprotection and improves cognitive function in rats. PLoS ONE 2010; 5: e11383.
34. Rosenberg G. The mechanisms of action of valproate in neuropsychiatric disorders: can we see the forest for the trees? Cell Mol Life Sci 2007; 64: 2090-2103.
35. Chen PS, Wang CC, Bortner CD, Peng GS, Wu X, Pang H, Lu RB, Gean PW, Chuang DM, Hong JS. Valproic acid and other histone deacetylase inhibitors induce microglial apoptosis and attenuate lipopolysaccharide-induced dopaminergic neurotoxicity. Neuroscience 2007; 149: 203-212.
36. Alsdorf R, Wyszynski DF. Teratogenicity of sodium valproate. Expert Opin Drug Saf 2005; 4: 345-353.
37. Gravemann U, Volland J, Nau H. Hydroxamic acid and fluorinated derivatives of valproic acid: anticonvulsant activity, neurotoxicity and teratogenicity. Neurotoxicol Teratol 2008; 30: 390-394.
38. Pokholok DK, Harbison CT, Levine S, Cole M, Hannett NM, Lee TI, Bell GW, Walker K, Rolfe PA, Herbolsheimer E, Zeitlinger J, Lewitter F, Gifford DK, Young RA. Genome-wide map of nucleosome acetylation and methylation in yeast. Cell 2005; 122: 517-527.
39. Wang Z, Zang C, Rosenfeld JA, Schones DE, Barski A, Cuddapah S, Cui K, Roh TY, Peng W, Zhang MQ, Zhao K. Combinatorial patterns of histone acetylations and methylations in the human genome. Nat Genet 2008; 40: 897-903.
40. Milutinovic S, D'Alessio AC, Detich N, Szyf M. Valproate induces widespread epigenetic reprogramming which involves demethylation of specific genes. Carcinogenesis 2007; 28: 560-571.
41. Detich N, Bovenzi V, Szyf M. Valproate induces replication-independent active DNA demethylation. J Biol Chem 2003; 278: 27586-27592.
42. Hillemacher T, Frieling H, Luber K, Yazici A, Muschler MA, Lenz B, Wilhelm J, Kornhuber J, Bleich S. Epigenetic regulation and gene expression of vasopressin and atrial natriuretic peptide in alcohol withdrawal. Psychoneuroendocrinology 2009; 34: 555-560.
43. Auger CJ, Coss D, Auger AP, Forbes-Lorman RM. Epigenetic control of vasopressin expression is maintained by steroid hormones in the adult male rat brain. Proc Natl Acad Sci USA 2011; 108: 4242-4247.
44. Wang Z, Bullock NA, De Vries GJ. Sexual differentiation of vasopressin projections of the bed nucleus of the stria terminals and medial amygdaloid nucleus in rats. Endocrinology 1993; 132: 2299-2306.
45. Murgatroyd C, Patchev AV, Wu Y, Micale V, Bockmuhl Y, Fischer D, Holsboer F, Wotjak CT, Almeida OF, Spengler D. Dynamic DNA methylation programs persistent adverse effects of early-life stress. Nat Neurosci 2009; 12: 1559-1566.
46. Yamauchi J, Miyamoto Y, Murabe M, Fujiwara Y, Sanbe A, Fujita Y, Murase S, Tanoue A. Gadd45a, the gene induced by the mood stabilizer valproic acid, regulates neurite outgrowth through JNK and the substrate paxillin in N1E-115 neuroblastoma cells. Exp Cell Res 2007; 313: 1886-1896.
47. Gaub P, Tedeschi A, Puttagunta R, Nguyen T, Schmandke A, Di Giovanni S. HDAC inhibition promotes neuronal outgrowth and counteracts growth cone collapse through CBP/p300 and P/CAF-dependent p53 acetylation. Cell Death Differ 2010; 17: 1392-1408.
48. Rivieccio MA, Brochier C, Willis DE, Walker BA, D'Annibale MA, McLaughlin K, Siddiq A, Kozikowski AP, Jaffrey SR, Twiss JL, Ratan RR, Langley B. HDAC6 is a target for protection and regeneration following injury in the nervous system. Proc Natl Acad Sci USA 2009; 106: 19599-19604.
49. Chapman A, Keane PE, Meldrum BS, Simiand J, Vernieres JC. Mechanism of anticonvulsant action of valproate. Prog Neurobiol 1982; 19: 315-359.
50. Loscher W. Effects of the antiepileptic drug valproate on metabolism and function of inhibitory and excitatory amino acids in the brain. Neurochem Res 1993; 18: 485-502.
51. Clarke A, File SE. Selective neurotoxin lesions of the lateral septum: changes in social and aggressive behaviours. Pharmacol Biochem Behav 1982; 17: 623-628.